Haiyun Shang

TUBB4B is a novel therapeutic target in non‐alcoholic fatty liver disease‐associated hepatocellular carcinoma

Lixia Xu, N. Wong, Jun Yu, 2023, The Journal of pathology.

TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target

Jun Yu, Hongyan Gou, Haiyun Shang, 2024, Oncogene.

TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.

Huarong Chen, C. Wong, Hongyan Gou, 2023, Cancer letters.